$14.62 0.00 (-0.03%)
12/4/2009 11:28 AM

Biovail Corp (USA) (BVF)

CAPS Rating: 4 out of 5

A specialty pharmaceutical company that applies advanced drug-delivery technologies to improve the clinical effectiveness of medicines. Its main therapeutic areas are central nervous system disorders, pain management and cardiovascular disease.

Recs

0
Member Avatar RxBodie (23.32) Submitted: 12/23/2007 8:57:19 PM : Outperform Start Price: $13.03 BVF Score: +0.63

Beaten down too far too fast. Generic business doing well. Branded products are losing patent protection but I feel it is already baked into the price. Dividend is very high for the time being.

Report this Post 0 Comments

Featured Broker Partners